David Qualls

10PUBLICATIONS
55CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 13, 2026
Allogeneic HCT as consolidation in B-cell lymphomas after exposure to bispecific antibodies: a GETH-TC study.

Marta Peña, Giulia Losi, Víctor Navarro

|Apr 03, 2025
Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia.

James T Yoon, Yinglu Zhou, Mariia Mikhaleva

|Nov 15, 2024
A real-world comparison of commercial-use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphoma.

Andrew Looka, David A Qualls, Daniel Matthews

|Sep 24, 2024
The current landscape of frontline large B-cell lymphoma trials.

David Qualls, Philippe Armand, Gilles Salles

|Sep 22, 2023
Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study.

David A Qualls, Nicholas Lambert, Paolo F Caimi

|Feb 07, 2023
Personalized approaches for treatment-naïve mantle cell lymphoma.

David Qualls, Anita Kumar

Pageof 2

Frequent Collaborators

3 joint publications

Gilles Salles

2 joint publications

Erin M Parry

2 joint publications

Ann S LaCasce

2 joint publications

Jennifer L Crombie